Delivery Order SPE2DR25D1053-SPE2DR26FT410
- Not listed
- The Defense Logistics Agency awarded a $6,483.54 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vial on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Phenobarbital 130 mg/ml vials, with a ceiling value of $1,346.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is set for ultimate completion by August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a delivery order, this award likely derives from...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Phenobarbital 130 mg/ml vials, with a contract ceiling value of $8,976.00 and an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 65 mg/mL vials, valued at $4,516.61. This non-set-aside, firm fixed-price delivery order is expected to be completed by August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- The Defense Logistics Agency awarded a $5,149.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Phenobarbital 130 mg/mL vials. This is a non-set-aside contract with an ultimate completion date of May 22, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 24, 2025, for Phenobarbital 65 mg/mL vials valued at $1,290.04 under a Firm Fixed Price contract type. The award, issued by the Medical Supply Chain division of the Defense Logistics Agency, requires performance at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 25, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $7,103.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml in vial format. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT410Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Phenobarbital 130 mg/mL in vial format, valued at $2,120.38. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for ultimate completion on October 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Logistics Agency's pharmaceutical supply chain. The company's comprehensive product portfolio encompasses a wide range of medications and medical supplies for military and veteran healthcare systems. This delivery order for Phenobarbital, a barbiturate commonly used in neurological and seizure management applications, represents a routine pharmaceutical supply transaction under the company's expansive global pharmaceutical support contract with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/29/25 |